EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:231241 |
| ChEBI Name | DL-allylglycine |
| Stars | |
| ASCII Name | DL-allylglycine |
| Definition | A racemate comprising equimolar amounts of (D)- and (L)-allylglycine. |
| Last Modified | 19 September 2024 |
| Submitter | MetaboLights |
| Formula | C5H9NO2 |
| Net Charge | 0 |
| Average Mass | 115.132 |
| Monoisotopic Mass | 115.06333 |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Mus musculus (ncbitaxon:10090) | feces (BTO:0000440) | MetaboLights (MTBLS9100) |
| Roles Classification |
|---|
| Biological Role: | EC 4.1.1.15 (glutamate decarboxylase) inhibitor An EC 4.1.1.* (carboxy-lyase) inhibitor that interferes with the action of glutamate decarboxylase (EC 4.1.1.15). |
| Application: | convulsant A drug that induces seizures or increases their severity. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| DL-allylglycine (CHEBI:231241) has part D-allylglycine (CHEBI:231977) |
| DL-allylglycine (CHEBI:231241) has part L-allylglycine (CHEBI:230523) |
| DL-allylglycine (CHEBI:231241) has role convulsant (CHEBI:231761) |
| DL-allylglycine (CHEBI:231241) has role EC 4.1.1.15 (glutamate decarboxylase) inhibitor (CHEBI:142581) |
| DL-allylglycine (CHEBI:231241) is a racemate (CHEBI:60911) |
| IUPAC Name |
|---|
| (2RS)-2-aminopent-4-enoic acid |
| Synonyms | Source |
|---|---|
| DL-2-amino-4-pentenoic acid | ChEBI |
| (RS)-2-amino-4-pentenoic acid | ChEBI |
| DL-C-allylglycine | ChEBI |
| DL-α-allylglycine | ChEBI |
| (±)-2-amino-4-pentenoic acid | ChEBI |
| DL-2-aminopent-4-enoic acid | NIST Chemistry WebBook |
| Manual Xrefs | Databases |
|---|---|
| HMDB0251510 | HMDB |
| 13425 | ChemSpider |
| Registry Numbers | Sources |
|---|---|
| CAS:7685-44-1 | NIST Chemistry WebBook |
| Citations |
|---|